Immunomedics Inc (IMMU) Return on Investment ROI from the second quarter of 2020 to second quarter of 2019 and for the year 2020, average high and low, overall ranking from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunomedics Inc   (NASDAQ: IMMU)


Immunomedics Inc's ROI from its second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immunomedics Inc's ROI in the second quarter of 2020?
Immunomedics Inc recorded a cumulative net loss of $-354 million during 12 months ending in the second quarter of 2020, resulting in a negative return on investment (ROI) of -57.2%.

Within the Healthcare sector 489 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2020 from 0 to 3809.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Investment Change TTM 95.11 % 52.09 % 17.79 % 13.67 % 81.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 995 526 599 353 432
Return On Investment (TTM) -57.2 % -76.03 % -90.35 % -136.59 % -126 %
IMMU's Overall Ranking # 3809 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 29.46 % 20.72 % 25.84 % -0.8 % 0.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -354 -363 -357 -429 -399

IMMU Company Profile >> Back to IMMU Roi Comparisons >> See Annual IMMU Return On Investment



Return On Investment IMMU's Ranking
Within: No.
Industry # 11
Sector # 490
Overall # 3809

Return On Investment Statistics
High Average Low
-47.17 %
-186.52 %
-1103.35 %
(Jun 30 2020)   (Jun 30 2017)







Financial Statements
Immunomedics Inc's II. Quarter Investments $ 995 Millions IMMU's Balance sheet
Immunomedics Inc's II. Quarter Income $ -66 Millions Quarterly IMMU's Income Statement
IMMU's Income by Division See IMMU's Income by Division


IMMU Annual Return On Investment (Dec 31 2019)
2019		 (Jun 30 2018)
2018		 (Jun 30 2017)
2017		 (Jun 30 2016)
2016		 (Jun 30 2015)
2015
Total Investments in Millions 599 421 40 41 93
Y / Y Investment Growth 42.39 % 963.28 % -3.08 % -56.15 % 133.48 %
Net Income in Millions -357 -274 -153 -59 -48
Y / Y Net Income Growth - - - - -
Annual Return On Investment -59.66 % -65.12 % -387.44 % -144.88 % -51.7 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMMU's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMMU's Competitors
Subscribers only: Roi for Immunomedics Inc's Suppliers
Subscribers only: Return On Investment for IMMU's Customers

Other Ratios
IMMU's Roa IMMU's Inventory Turnover Ratio IMMU's Growth Rates IMMU's Dividend Statistics
IMMU's Profitability Ratios IMMU's Asset Turnover Ratio IMMU's Dividend Growth
IMMU's Roe IMMU's Valuation Ratios IMMU's Financial Strength Ratios IMMU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.